Literature DB >> 21517768

The use of cyclodextrins nanoparticles for oral delivery.

J R Kanwar1, B M Long, R K Kanwar.   

Abstract

This review aims to highlight many of the difficulties encountered in trying to achieve the task of delivering proteins and peptides through oral administration. The necessity of controlled protein and peptide release, protection and stability in the gastrointestinal tract, and ability to target specific areas are only a handful of the many problems associated with trying to engineer a useful solution. Current research gives strong indication that both cyclodextrins and nanoparticles could be highly useful in the search for a suitable method for such successful oral delivery of proteins and peptides. This review focuses on the use of cyclodextrins in pharmaceuticals, aiming to discuss the use of cyclodextrins in conjunction with nanoparticles for oral delivery of proteins. Both classical applications and more advanced "nanomedical" approaches are discussed. In order to achieve a complete overview this review will include background information about cyclodextrins, nanomedicine and their role in oral delivery systems. The use of absorption enhancers like cyclodextrins, bile salts and surfactants was used to facilitate bio-availability into the system. The state-of-the-art technology and challenges in this area are discussed, with typical examples.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517768     DOI: 10.2174/092986711795656243

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity.

Authors:  Maurizio Viale; Graziella Vecchio; Massimiliano Monticone; Vittorio Bertone; Valentina Giglio; Irena Maric; Michele Cilli; Vittorio Bocchini; Aldo Profumo; Mirco Ponzoni; Laura Emionite; Mattia Rocco
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

2.  New doxorubicin nanocarriers based on cyclodextrins.

Authors:  Maurizio Viale; Valentina Giglio; Massimiliano Monticone; Irena Maric; Giovanni Lentini; Mattia Rocco; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-04-04       Impact factor: 3.850

Review 3.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

4.  Cyclodextrin polymers as nanocarriers for sorafenib.

Authors:  Valentina Giglio; Maurizio Viale; Vittorio Bertone; Irena Maric; Rita Vaccarone; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-11-08       Impact factor: 3.850

5.  In vitro and in vivo anticandidal activities of alginate-enclosed chitosan-calcium phosphate-loaded Fe-bovine lactoferrin nanocapsules.

Authors:  Khoo Miew Leng; Soundararajan Vijayarathna; Subramanion L Jothy; Sreenivasan Sasidharan; Jagat R Kanwar
Journal:  Future Sci OA       Date:  2017-11-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.